The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Findings from two clinical studies were reported at Digestive Disease Week earlier this month that supported use of the firm's EsoCheck device and EsoGuard test.
Biocept Prices $5M Public Offering
The San Diego-based company plans to use the proceeds to advance its cerebral spinal fluid liquid biopsy assay, as well as to boost its working capital.
Genetron Health Receives Nasdaq Noncompliance Notice
The Chinese cancer molecular profiling company has 180 calendar days, or until Nov. 13, to regain compliance with the Nasdaq minimum bid price requirement.
Agilent Technologies Fiscal Q2 Revenues Rise 7 Percent as Firm Lowers 2023 Guidance
Diagnostics and Genomics Group revenues were up 1 percent year over year, growing less than revenues for the company's other two business segments.
Theralink to Become Subsidiary of IMAC via Stock-for-Stock Reverse Merger
Theralink will become a wholly owned subsidiary of IMAC focused on proteomic testing for guiding cancer therapy and drug development.